Page last updated: 2024-08-24
epigallocatechin gallate and Acquired Nephrogenic Diabetes Insipidus
epigallocatechin gallate has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Guo, LL; Jin, HM; Pan, Y; Yang, XH; Zhan, XL; Zhang, BL | 1 |
Other Studies
1 other study(ies) available for epigallocatechin gallate and Acquired Nephrogenic Diabetes Insipidus
Article | Year |
---|---|
Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice.
Topics: Animals; Catechin; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Kidney; Mice; Mice, Inbred C57BL; Oxidative Stress | 2016 |